Twin-Twin Transfusion Syndrome: Fetoscopic Laser Outcomes

Twin-twin transfusion syndrome (TTTS) is a serious complication of monochorionic twin pregnancy, in which identical twins share one placenta. Connecting blood vessels within that placenta can create an imbalanced circulation: one twin becomes the donor, losing blood and amniotic fluid, while the recipient twin receives excessive blood and may develop cardiac strain. Fetoscopic laser treatment aims to interrupt the abnormal placental connections and restore a safer circulation for both babies.

For Australian families, diagnosis often means rapid referral from a local obstetrician or ultrasound service to a fetal medicine unit in Sydney, Melbourne, Brisbane, Adelaide or Perth. The FAOPS 2020 congress archive provides useful historical context for the regional scientific community that discusses perinatal medicine, neonatal care and fetal therapy.

Recognising TTTS and Referral

TTTS usually develops in monochorionic diamniotic twins, commonly called MCDA twins. Routine ultrasound can identify the shared placenta early, but the condition itself is diagnosed through findings such as unequal amniotic fluid, an absent or very small bladder in the donor twin, abnormal blood-flow studies and signs of cardiovascular stress in the recipient. Regular surveillance is generally recommended from around 16 weeks of pregnancy, with the interval determined by the treating fetal medicine team.

The Quintero staging system describes increasing severity. Stage I involves fluid imbalance with a visible donor bladder; stage II is marked by a donor bladder that cannot be seen; stage III includes critically abnormal Doppler blood-flow patterns; stage IV involves hydrops or significant fetal heart failure. Stage V refers to fetal death. The stage helps guide management, although clinical decisions also consider gestational age, cervical length, maternal health, fetal anatomy and the speed of progression.

Suspected TTTS should be assessed urgently rather than managed through routine antenatal appointments alone. In Australia, a woman living in regional New South Wales or northern Queensland may need air or road transfer to a tertiary fetal therapy service. Early referral matters because fetoscopic laser is most effective when the disease is diagnosed before irreversible injury occurs.

How Fetoscopic Laser Therapy Works

Fetoscopic laser photocoagulation is performed under ultrasound guidance, usually with maternal sedation or anaesthesia. A small fetoscope passes through the maternal abdomen and uterus into the shared amniotic sac. The surgeon identifies placental vascular connections crossing between the twins’ territories and seals them with laser energy. The aim is to separate the circulations while preserving as much healthy placental tissue as possible.

Many centres use the Solomon technique, which adds a laser line across the placental surface between the individual treatment points. This may reduce the chance of tiny residual connections causing recurrent transfusion or twin anaemia-polycythaemia sequence (TAPS). Some procedures use a selective approach without the additional equatorial line. The choice depends on placental anatomy, visibility, gestational age and the surgeon’s experience.

After the vascular connections are treated, excessive amniotic fluid is usually drained through the fetoscope. This can relieve maternal discomfort, reduce uterine pressure and improve access to the placenta. Laser is not a guarantee that both twins will survive, and it cannot reverse established brain injury, severe cardiac damage or complications caused by very early delivery. It is, however, the standard definitive treatment for many cases of stage II to IV TTTS.

What Outcomes Families Can Expect

Reported results vary between countries, hospitals, disease stages and study periods. In experienced fetal therapy programmes, survival of at least one twin is commonly reported in roughly 80% to 90% of treated pregnancies, while survival of both twins is often around 60% to 75%. These figures are broad clinical ranges rather than a personal forecast. Earlier gestation, advanced Quintero stage, abnormal Dopplers and fetal growth restriction can lower the likelihood of a favourable outcome.

The main immediate risks include miscarriage, preterm prelabour rupture of membranes, infection, placental bleeding and emergency delivery. Recurrent TTTS is uncommon after complete vascular separation, but residual anastomoses can contribute to recurrent fluid imbalance or TAPS. Selective fetal growth restriction may remain a concern if one twin has a much smaller share of the placenta.

Neurological outcome is a crucial part of counselling. Severe TTTS can expose either twin to low blood flow, high blood pressure or sudden haemodynamic change, and these events may affect the brain. Follow-up studies assess cerebral palsy, developmental delay, hearing, vision, motor skills and learning. Parents may also hear about neonatal outcomes such as respiratory distress, necrotising enterocolitis, intraventricular haemorrhage and the length of neonatal intensive care.

Fetal and newborn assessment should be integrated. Delivery-room teams may use measures such as cord blood gases to evaluate acid-base status after birth; a practical discussion of this approach appears in cord blood gas analysis. Cord results do not replace neurological examinations or developmental surveillance, but they can add context when clinicians interpret the newborn’s condition.

Australian Care Pathways and Practicalities

Australia has a concentrated fetal surgery market, with specialist services located mainly in major metropolitan hospitals. Families may be referred through a public maternity service, a private obstetrician or a maternal-fetal medicine specialist. Access arrangements differ by state, and a procedure may require coordination between the referring hospital, a fetal therapy centre, neonatal intensive care and local follow-up providers.

Medicare can cover medically necessary hospital and specialist care in the public system, while private patients may face out-of-pocket expenses, insurance limits and travel costs. Accommodation near a Sydney or Melbourne hospital, time away from work and care for other children can become significant burdens. Families from Perth, Darwin or remote inland communities may need to plan flights, temporary relocation and support after discharge. Hospital social workers and state-based patient travel schemes can explain eligibility, but rules differ across jurisdictions.

Australian pregnancy care also reflects long travel distances and varied local resources. A woman in regional Victoria might have regular ultrasound locally and travel to Melbourne for fetal therapy, whereas a family in Queensland may coordinate care between a regional hospital and Brisbane. Telehealth can support consultations and updates, although detailed ultrasound, surgery and neonatal treatment still require in-person services. Keeping copies of ultrasound reports, Doppler measurements and medication information can help when care crosses hospital networks.

Consent should cover the potential benefits and limits of laser, the possibility of treating only one twin, the chance of early delivery and the option of expectant management in carefully selected circumstances. Clinicians should also explain how Australian privacy obligations affect the sharing of scans and medical records between public hospitals, private practices and interstate services. Families can ask who will provide emergency care if membranes rupture after returning home and which symptoms require immediate presentation to hospital.

Interpreting Evidence and Long-Term Follow-Up

Outcomes are best understood by separating procedural success from family-centred results. Technical completion of laser does not necessarily mean that both twins will survive, and survival does not automatically indicate healthy development. Studies may report pregnancy survival, neonatal survival, intact survival, gestational age at birth or neurodevelopment at two years, so apparently different results may reflect different definitions and follow-up periods.

The table below summarises the broad clinical picture. It is intended for orientation, not individual risk calculation.

Long-term follow-up commonly includes neonatal brain imaging, hearing and vision checks, developmental screening and review by paediatric or allied health teams. In Australia, follow-up may be shared between a neonatal service in a capital city and a paediatrician or community health team closer to home. Families should keep appointments even when both babies appear well, because mild language, motor or behavioural differences may become clearer after infancy.

Research continues to compare laser methods, improve placental mapping and identify which fetuses are most vulnerable to neurological injury. Specialist centres also monitor the surviving twin after single fetal death, because the shared circulation can place the co-twin at immediate risk. The evidence is strongest when outcomes are reported transparently by gestational age, stage, procedure type and length of developmental follow-up.

Families seeking the broader setting for this field can explore the FAOPS 2020 congress archive, which records a regional scientific meeting focused on perinatal and neonatal medicine. Although the Tokyo congress was cancelled in April 2020 because of the COVID-19 pandemic and international travel restrictions, its subject area remains highly relevant to fetal therapy and newborn care.

A diagnosis of TTTS deserves prompt review by a maternal-fetal medicine team with experience in monochorionic pregnancies and fetoscopic treatment. Ask for a clear explanation of the stage, placental anatomy, recommended timing, likely travel arrangements and the follow-up plan for both babies. Early specialist coordination can help Australian families make informed decisions while bringing obstetric, fetal surgery and neonatal care into one pathway.